Disease progression and survival following specific AIDS-defining conditions: a retrospective cohort study of 2048 HIV-infected persons in London

被引:38
作者
Petruckevitch, A
Del Amo, J
Phillips, AN
Johnson, AM
Stephenson, J
Desmond, N
Hanscheid, T
Low, N
Newell, A
Obasi, A
Paine, K
Pym, A
Theodore, C
De Cock, KM
机构
[1] UCL, Sch Med, Mortimer Market Ctr,Dept STD, MRC UK Ctr Coordinating Epidemiol Studies HIV & A, London W1N 8AA, England
[2] Royal Free Hosp, Sch Med, Dept Primary Care & Populat Sci, London, England
[3] Univ London St Georges Hosp, London, England
[4] London Sch Hyg & Trop Med, London WC1, England
[5] Kings Coll Hosp London, London, England
[6] Chelsea & Westminster Hosp, London, England
[7] UCL Hosp, London, England
[8] St Marys Hosp, London, England
[9] Charing Cross Hosp, London, England
关键词
AIDS; progression; tuberculosis; survival; London;
D O I
10.1097/00002030-199809000-00006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: To assess the impact of specific AIDS-defining conditions on survival in HIV-infected persons, with emphasis on the effect of tuberculosis. Methods: A retrospective cohort analysis of HIV-infected Africans and non-Africans attending 11 specialist HIV/AIDS units in London enrolled for a comparison of the natural history of HIV/AIDS in different ethnic groups. Results: A total of 2048 patients were studied of whom 627 (31%) developed 1306 different AIDS indicator diseases. Pneumocystis carinii pneumonia accounted for 159 (25%) of initial AIDS episodes and tuberculosis for 103 (16%). In patients with HIV disease, tuberculosis had the lowest risk [relative risk (RR), 1.11; 95% confidence interval (CI), 0.75-1.63], and high-grade lymphoma had the highest risk (RR, 20.56; 95% CI, 2.70-156.54) for death. For patients with a prior AIDS-defining illness, the development of subsequent AIDS indicator diseases such as Pneumocystis carinii pneumonia (RR, 1.18; 95% CI, 0.77-1.83) and tuberculosis (RR, 1.36; 95% CI, 0.76-2.47) had the best survival, and non-Hodgkin's lymphoma had the worst survival (RR, 9.67; 95% CII 1.26-74.33). Patients with tuberculosis had a lower incidence of subsequent AIDS-defining conditions than persons with other initial AIDS diagnoses (rate ratio, 0.47; 95% CI, 0.37-0.59). Conclusions: Considerable variation exists in the relative risk of death following different AIDS-defining conditions. The development of any subsequent AIDS-defining condition is associated with an increased risk of death that differs between diseases, and this risk should be considered when evaluating the impact of specific conditions. Like other AIDS-defining conditions, incident tuberculosis was associated with adverse outcome compared with the absence of an AIDS-defining event, but we found no evidence of major acceleration of HIV disease attributable to tuberculosis. (C) 1998 Lippincott-Raven Publishers.
引用
收藏
页码:1007 / 1013
页数:7
相关论文
共 19 条
[1]   RESPONSE TO TREATMENT, MORTALITY, AND CD4 LYMPHOCYTE COUNTS IN HIV-INFECTED PERSONS WITH TUBERCULOSIS IN ABIDJAN, COTE-DIVOIRE [J].
ACKAH, AN ;
COULIBALY, D ;
DIGBEU, H ;
DIALLO, K ;
VETTER, KM ;
COULIBALY, IM ;
GREENBERG, AE ;
DECOCK, KM .
LANCET, 1995, 345 (8950) :607-610
[2]   EXPANDED EUROPEAN AIDS CASE DEFINITION [J].
ANCELLEPARK, R .
LANCET, 1993, 341 (8842) :441-441
[3]   TRENDS IN SURVIVAL AMONG PERSONS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME IN NEW-YORK-CITY - THE EXPERIENCE OF THE FIRST DECADE OF THE EPIDEMIC [J].
BLUM, S ;
SINGH, TP ;
GIBBONS, J ;
FORDYCE, EJ ;
LESSNER, L ;
CHIASSON, MA ;
WEISFUSE, IB ;
THOMAS, PA .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 139 (04) :351-361
[4]  
CAYLA JA, 1994, MED CLIN-BARCELONA, V102, P129
[5]  
[Anonymous], 1992, MMWR Recomm Rep, V41, P1
[6]   Spectrum of disease in Africans with AIDS in London [J].
DelAmo, J ;
Petruckevitch, A ;
Phillips, AN ;
Johson, AM ;
Stephenson, JM ;
Desmond, N ;
Hanscheid, T ;
Low, N ;
Newell, A ;
Obasi, A ;
Paine, K ;
Pym, A ;
Theodore, CM ;
DeCock, KM .
AIDS, 1996, 10 (13) :1563-1569
[7]  
DELAMO J, 1998, IN PRESS AIDS, V12
[8]  
Goletti D, 1996, J IMMUNOL, V157, P1271
[9]   SURVIVAL DIFFERENCES IN EUROPEAN PATIENTS WITH AIDS, 1979-89 [J].
LUNDGREN, JD ;
PEDERSEN, C ;
CLUMECK, N ;
GATELL, JM ;
JOHNSON, AM ;
LEDERGERBER, B ;
VELLA, S ;
PHILLIPS, A ;
NIELSEN, JO ;
DEWIT, S ;
SOMMEREIJNS, B ;
NIELSEN, T ;
JENSEN, G ;
SKINHOJ, P ;
BENTSEN, K ;
GERSTOFT, J ;
MELBYE, M ;
RANKI, A ;
VALLE, SL ;
KATLAMA, C ;
BERLUREAU, P ;
DIETRICH, M ;
SCHWANDER, S ;
GOEBEL, FD ;
KOSMIDIS, J ;
STERGIOU, G ;
GOUZIA, T ;
PAPADOPOULOS, A ;
BANHEGYI, D ;
MULCAHY, F ;
YUST, I ;
BENISHAI, Z ;
BENTWICH, Z ;
SACKS, T ;
MAAYAN, S ;
CHIESI, A ;
ANCARANI, F ;
SCALISE, G ;
BERTAGGIA, A ;
FRANCAVILLA, E ;
CALONGHI, G ;
CARGNEL, A ;
ARLOTTI, M ;
CIAMMARUGHI, R ;
COLOMBA, A ;
DELALLA, F ;
FASSIO, P ;
FERLINI, A ;
FIACCADORI, F ;
PASETTI, G .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6936) :1068-1073
[10]   Prognosis in HIV-1 infection predicted by the quantity of virus in plasma [J].
Mellors, JW ;
Rinaldo, CR ;
Gupta, P ;
White, RM ;
Todd, JA ;
Kingsley, LA .
SCIENCE, 1996, 272 (5265) :1167-1170